The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer
- 15 February 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (7) , 775-787
- https://doi.org/10.1038/sj.onc.1204159
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 55 references indexed in Scilit:
- Requirements for Repression of Retinoid X Receptor by the Oncoprotein P75gag-v-erbA and the Thyroid Hormone ReceptorsMolecular Endocrinology, 1998
- Thyroid Hormone Response Element Architecture Affects Corepressor Release from Thyroid Hormone Receptor DimersJournal of Biological Chemistry, 1998
- Avian erythropoiesis and erythroleukemia: towards understanding the role of the biomolecules involvedBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- The Transcriptional Coactivators p300 and CBP Are Histone AcetyltransferasesPublished by Elsevier ,1996
- DNA Recognition by Normal and Oncogenic Thyroid Hormone ReceptorsJournal of Biological Chemistry, 1996
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressorNature, 1995
- Transcription Factor Loading on the MMTV Promoter: A Bimodal Mechanism for Promoter ActivationScience, 1992
- v-erbA Oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor actionCell, 1991
- Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene productNature, 1989